Gudcef 50mg Tablet DT contains Cefpodoxime Proxetil, a third-generation oral cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea caused by susceptible strains. Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible form, facilitating ease of administration, especially in pediatric and geriatric populations. Gudcef 50mg Tablet DT is rapidly absorbed in the gastrointestinal tract and converted to the active form, cefpodoxime, achieving therapeutic plasma concentrations. It is generally well tolerated, with common adverse effects including gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be adjusted based on the severity of infection, patient age, and renal function. It is essential to complete the full prescribed course to prevent the development of resistance. Gudcef 50mg Tablet DT should be used under medical supervision, with caution in patients with hepatic or renal impairment.